In all my days I have not been involved in an approval that takes the stock for a down turn. Now that this label is being worked out and the competition has been delayed. I see little reason why the share price is not beating up new 52 week highs. The scripts will continue to gain. Some months maybe smaller than others, but the script growth is going to continue. The added bonus that blood pressures decrease with Valtessa usage is truly unremarkable.
I sure hope more posters come to IHUB. Yahoo RLYP financial board is very hard on the eyes for the time being.
News 
Market Data 
Discover 
